EGFR Inhibitor

CAS No. 879127-07-8

EGFR Inhibitor ( —— )

Catalog No. M19965 CAS No. 879127-07-8

EGFR inhibitor is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 146 In Stock
10MG 245 In Stock
25MG 492 In Stock
50MG 701 In Stock
100MG 954 In Stock
500MG 1908 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    EGFR Inhibitor
  • Note
    Research use only not for human use.
  • Brief Description
    EGFR inhibitor is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.
  • Description
    EGFR inhibitor is a cell permeable and selective inhibitor of EGFR kinase (IC50: 21 nM) and blocks receptor autophosphorylation in cells.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; EGFR (L858R); EGFR (L861Q)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    879127-07-8
  • Formula Weight
    413.4
  • Molecular Formula
    C21H18F3N5O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 25 mg/mL;Ethanol: 10 mg/mL
  • SMILES
    FC(F)(F)c1cccc(Nc2cc(Nc3cccc(NC(=O)C4CC4)c3)ncn2)c1
  • Chemical Name
    N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Zhang Q et al. Discovery of EGFR selective 46-disubstituted pyrimidines from a combinatorial kinase-directed heterocycle library. J Am Chem Soc. 2006 Feb 22;128(7):2182-3.
molnova catalog
related products
  • Cetuximab (anti-EGFR...

    Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).

  • WHI-P258

    WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.

  • Alflutinib

    Alflutinib (AST-2818, ASK120067) is a third generation EGFR mutation selective tyrosine kinase inhibitor.